Marker Therapeutics, Inc.

Daily Archives: Wednesday, September 5, 2018

Baylor, MD Anderson Cancer Therapies Advance Toward Commercialization

Recently, two TMC member institutions saw their cancer therapies gain the distinction of advancing to commercialization.

Read More